{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"groupId":"OG001","spread":"1.1","value":"0.5"},{"groupId":"OG002","spread":"0.6","value":"0.4"},{"groupId":"OG003","spread":"0.7","value":"0.6"},{"groupId":"OG004","spread":"1.6","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.3"},{"groupId":"OG001","spread":"1.3","value":"0.5"},{"groupId":"OG002","spread":"0.4","value":"0.3"},{"groupId":"OG003","spread":"1.1","value":"1.0"},{"groupId":"OG004","spread":"0.2","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 2"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.5","value":"0.2"},{"groupId":"OG001","spread":"1.5","value":"0.7"},{"groupId":"OG002","spread":"0.1","value":"0.1"},{"groupId":"OG003","spread":"0.1","value":"0.9"},{"groupId":"OG004","spread":"0.1","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 3"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"0.1"},{"groupId":"OG001","spread":"1.8","value":"0.8"},{"groupId":"OG002","spread":"0.3","value":"0.3"},{"groupId":"OG003","spread":"0.8","value":"0.7"},{"groupId":"OG004","spread":"0.4","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 4"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"groupId":"OG001","spread":"1.4","value":"0.6"},{"groupId":"OG002","spread":"0.5","value":"0.3"},{"groupId":"OG003","spread":"0.6","value":"0.6"},{"groupId":"OG004","spread":"0.2","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.2"},{"groupId":"OG001","spread":"1.8","value":"0.8"},{"groupId":"OG002","spread":"0.5","value":"0.3"},{"groupId":"OG003","spread":"1.0","value":"0.7"},{"groupId":"OG004","spread":"0.3","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 6"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.3"},{"groupId":"OG001","spread":"1.9","value":"0.9"},{"groupId":"OG002","spread":"0.3","value":"0.2"},{"groupId":"OG003","spread":"0.6","value":"0.4"},{"groupId":"OG004","spread":"0.1","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 7"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.3"},{"groupId":"OG001","spread":"1.8","value":"0.8"},{"groupId":"OG002","spread":"0.5","value":"0.2"},{"groupId":"OG003","spread":"0.9","value":"0.6"},{"groupId":"OG004","spread":"0.4","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 8"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.9","value":"0.4"},{"groupId":"OG001","spread":"0.9","value":"0.5"},{"groupId":"OG002","spread":"0.3","value":"0.2"},{"groupId":"OG003","spread":"0.7","value":"0.5"},{"groupId":"OG004","spread":"0.3","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 9"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.9","value":"0.5"},{"groupId":"OG001","spread":"0.8","value":"0.4"},{"groupId":"OG002","spread":"0.1","value":"0.1"},{"groupId":"OG003","spread":"0.4","value":"0.2"},{"groupId":"OG004","spread":"0.2","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 10"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.0","value":"0.5"},{"groupId":"OG001","spread":"0.9","value":"0.5"},{"groupId":"OG002","spread":"0.2","value":"0.2"},{"groupId":"OG003","spread":"0.6","value":"0.4"},{"groupId":"OG004","spread":"0.1","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 11"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.4","value":"0.5"},{"groupId":"OG001","spread":"2.0","value":"0.9"},{"groupId":"OG002","spread":"0.4","value":"0.3"},{"groupId":"OG003","spread":"0.6","value":"0.3"},{"groupId":"OG004","spread":"0.2","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 12"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.2","value":"0.7"},{"groupId":"OG001","spread":"1.6","value":"0.6"},{"groupId":"OG002","spread":"0.4","value":"0.3"},{"groupId":"OG003","spread":"0.4","value":"0.2"},{"groupId":"OG004","spread":"0.4","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 13"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.2","value":"0.6"},{"groupId":"OG001","spread":"1.8","value":"0.7"},{"groupId":"OG002","spread":"0.3","value":"0.3"},{"groupId":"OG003","spread":"0.6","value":"0.4"},{"groupId":"OG004","spread":"0.4","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 14"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"groupId":"OG001","spread":"1.7","value":"0.7"},{"groupId":"OG002","spread":"0.5","value":"0.4"},{"groupId":"OG003","spread":"0.4","value":"0.4"},{"groupId":"OG004","spread":"1.6","value":"0.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.5","value":"0.4"},{"groupId":"OG001","spread":"1.8","value":"0.8"},{"groupId":"OG002","spread":"0.4","value":"0.4"},{"groupId":"OG003","spread":"0.5","value":"0.4"},{"groupId":"OG004","spread":"0.7","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 16"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"groupId":"OG001","spread":"1.8","value":"0.8"},{"groupId":"OG002","spread":"0.7","value":"0.5"},{"groupId":"OG003","spread":"0.6","value":"0.4"},{"groupId":"OG004","spread":"0.5","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 17"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"groupId":"OG001","spread":"1.8","value":"0.7"},{"groupId":"OG002","spread":"0.4","value":"0.3"},{"groupId":"OG003","spread":"0.1","value":"0.1"},{"groupId":"OG004","spread":"0.5","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 18"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"groupId":"OG001","spread":"2.0","value":"0.8"},{"groupId":"OG002","spread":"0.7","value":"0.4"},{"groupId":"OG003","spread":"0.8","value":"0.5"},{"groupId":"OG004","spread":"0.5","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 19"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"0.0"},{"groupId":"OG001","spread":"1.9","value":"0.8"},{"groupId":"OG002","spread":"0.8","value":"0.6"},{"groupId":"OG003","spread":"0.1","value":"0.1"},{"groupId":"OG004","spread":"0.4","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 20"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.3"},{"groupId":"OG001","spread":"1.9","value":"0.9"},{"groupId":"OG002","spread":"0.5","value":"0.5"},{"groupId":"OG003","spread":"0.1","value":"0.1"},{"groupId":"OG004","spread":"0.3","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 21"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"0.2"},{"groupId":"OG001","spread":"2.0","value":"0.8"},{"groupId":"OG002","spread":"1.5","value":"0.9"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"groupId":"OG004","spread":"0.6","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 22"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"groupId":"OG001","spread":"2.2","value":"0.8"},{"groupId":"OG002","spread":"0.7","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"groupId":"OG004","spread":"0.6","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 23"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.4"},{"groupId":"OG001","spread":"2.3","value":"1.0"},{"groupId":"OG002","spread":"0.7","value":"0.5"},{"groupId":"OG003","spread":"0.1","value":"0.0"},{"groupId":"OG004","spread":"0.3","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 24"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"0.2"},{"groupId":"OG001","spread":"0.2","value":"0.2"},{"groupId":"OG002","spread":"0.4","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"groupId":"OG004","spread":"0.1","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 25"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.8","value":"0.6"},{"groupId":"OG001","spread":"4.4","value":"3.3"},{"groupId":"OG002","spread":"0.6","value":"0.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 26"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.3"},{"groupId":"OG001","spread":"2.5","value":"1.1"},{"groupId":"OG002","spread":"0.6","value":"0.5"},{"groupId":"OG003","spread":"0.1","value":"0.1"},{"groupId":"OG004","spread":"0.4","value":"0.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 27"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.5"},{"groupId":"OG001","spread":"2.6","value":"1.2"},{"groupId":"OG002","spread":"0.7","value":"0.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"groupId":"OG004","spread":"0.2","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 28"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"0.2"},{"groupId":"OG001","spread":"2.1","value":"0.8"},{"groupId":"OG002","spread":"0.7","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"groupId":"OG004","spread":"0.2","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 29"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.1","value":"0.7"},{"groupId":"OG001","spread":"1.9","value":"0.7"},{"groupId":"OG002","spread":"0.8","value":"0.8"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"groupId":"OG004","spread":"0.1","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 30"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.3"},{"groupId":"OG001","spread":"0.1","value":"0.0"},{"groupId":"OG002","spread":"0.9","value":"1.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"groupId":"OG004","spread":"0.1","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 31"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.4"},{"groupId":"OG001","spread":"0.1","value":"0.1"},{"groupId":"OG002","spread":"0.9","value":"1.0"},{"groupId":"OG004","spread":"0.3","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 32"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.3"},{"groupId":"OG001","spread":"0.2","value":"0.1"},{"groupId":"OG002","spread":"1.0","value":"1.0"},{"groupId":"OG004","spread":"0.2","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 33"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"0.2"},{"groupId":"OG001","spread":"2.4","value":"1.3"},{"groupId":"OG002","spread":"0.5","value":"0.8"},{"groupId":"OG004","spread":"0.3","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 34"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"groupId":"OG002","spread":"0.7","value":"1.2"},{"groupId":"OG003","spread":"0.9","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 35"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.5"},{"groupId":"OG001","spread":"0.3","value":"0.2"},{"groupId":"OG002","spread":"0.6","value":"1.2"},{"groupId":"OG004","spread":"0.2","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 36"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.4"},{"groupId":"OG001","spread":"0.1","value":"0.1"},{"groupId":"OG002","spread":"0.8","value":"1.1"},{"groupId":"OG004","spread":"0.3","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 37"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.1"},{"groupId":"OG002","spread":"0.4","value":"1.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 38"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.9","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"groupId":"OG002","spread":"0.5","value":"1.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 39"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"groupId":"OG002","spread":"0.4","value":"0.9"},{"groupId":"OG004","spread":"0.2","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 40"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.6"},{"groupId":"OG001","spread":"1.6","value":"0.7"},{"groupId":"OG002","spread":"1.2","value":"1.4"},{"groupId":"OG004","spread":"0.4","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 41"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.5","value":"0.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 42"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.4","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG003","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 43"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"1.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"groupId":"OG002","spread":"0.3","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 44"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.7","value":"0.8"},{"groupId":"OG001","spread":"0.2","value":"0.1"},{"groupId":"OG002","spread":"1.2","value":"1.0"},{"groupId":"OG004","spread":"0.4","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 45"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.7","value":"1.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 46"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 47"},{"categories":[{"measurements":[{"groupId":"OG001","spread":"0.9","value":"0.8"},{"groupId":"OG002","spread":"0.2","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 48"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.6"},{"groupId":"OG001","spread":"0.0","value":"0.0"},{"groupId":"OG002","spread":"1.4","value":"1.1"},{"groupId":"OG004","spread":"0.4","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 49"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"1.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 50"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.2","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 51"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.4"},{"groupId":"OG001","spread":"0.5","value":"0.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 52"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.2"},{"groupId":"OG001","spread":"1.5","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"groupId":"OG004","spread":"0.3","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 53"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.8"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 54"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.5","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 55"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.2"},{"groupId":"OG002","spread":"0.1","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 56"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.3"},{"groupId":"OG001","spread":"0.0","value":"0.0"},{"groupId":"OG002","spread":"2.1","value":"1.5"},{"groupId":"OG004","spread":"0.3","value":"0.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 57"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 58"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 59"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 60"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.4"},{"groupId":"OG001","spread":"0.5","value":"0.3"},{"groupId":"OG002","spread":"2.1","value":"1.5"},{"groupId":"OG004","spread":"0.5","value":"0.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 61"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.0","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 62"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.7","value":"0.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 63"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"1.1"},{"groupId":"OG002","spread":"0.2","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 64"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0","value":"0.2"},{"groupId":"OG001","spread":"0.0","value":"0.0"},{"groupId":"OG002","spread":"1.3","value":"0.8"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 65"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.7","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 66"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 67"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"1.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 68"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.2"},{"groupId":"OG001","spread":"0.5","value":"0.3"},{"groupId":"OG002","spread":"2.1","value":"1.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 69"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.0","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"1.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 70"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.1","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 71"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG001","spread":"NA","value":"1.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 72"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.3","value":"0.4"},{"groupId":"OG001","spread":"0.0","value":"0.0"},{"groupId":"OG002","spread":"1.8","value":"1.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 73"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.7","value":"1.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 74"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"1.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 75"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 76"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"1.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 77"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"1.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 78"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"1.4"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 79"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"1.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 80"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 81"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 82"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 83"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 84"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 85"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.6"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 86"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 89"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG000","spread":"NA","value":"0.7"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 90"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 91"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 92"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 93"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 94"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.5"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 95"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 96"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 97"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.0"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 98"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 99"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 100"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 101"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 102"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.3"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 103"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.2"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 104"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG002","spread":"NA","value":"0.1"},{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 105"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 107"},{"categories":[{"measurements":[{"comment":"SD is not evaluable when only one participant is analyzed","groupId":"OG004","spread":"NA","value":"0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"Week 108"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.6","value":"0.4"},{"groupId":"OG001","spread":"1.8","value":"0.6"},{"groupId":"OG002","spread":"0.8","value":"0.5"},{"groupId":"OG003","spread":"1.0","value":"0.8"},{"groupId":"OG004","spread":"0.2","value":"0.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"title":"End of Treatment"}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"}],"units":"Participants"}],"description":"The TINAS is an 11-item questionnaire that assesses the severity of neuropathy-related symptoms in the last 24 hours. The 11 items assessed were: hot/burning sensations in hands/feet, sensations pins and needles arms/legs, numbness or tingling in hands/feet, sensations of electric shock, pain when touching cold things, cramps in hands/feet, discomfort when touching things, discomfort skin contact with something, trouble grasping small objects, trouble walking loss feeling legs/feet, difficulty balance loss feeling leg/feet. Each item was scored on a 0-10 scale, with 0 being the symptom is not present, and 10 being the symptom is as bad as the participant can imagine. Higher scores indicate more severe disease. Scores were averaged at each week.","dispersionType":"Standard Deviation","groups":[{"description":"Participants with FL received pola, 1.8 mg/kg, as IV infusion on Day 2 of Cycle 1 (each cycle is 28 days), and thereafter on Day 1 of Cycles 2 to 6. Participants also received bendamustine 90 mg/m\\^2, as IV infusion on Days 2 and 3 of Cycle 1, and thereafter on Days 1 and 2 of Cycles 2 to 6 and rituximab, 375 mg/m\\^2, as IV infusion on Day 1 of Cycles 1 to 6, in combination with pola.","id":"OG000","title":"Arm A (Phase II Randomization): Pola+BR in FL"},{"description":"Participants with FL received bendamustine 90 mg/m\\^2, as IV infusion on Days 2 and 3 of Cycle 1 (each cycle is 28 days), thereafter on Days 1 and 2 of Cycles 2 to 6 in combination with rituximab, 375 mg/m\\^2, as IV infusion on Day 1 of Cycles 1 to 6.","id":"OG001","title":"Arm B (Phase II Randomization): BR in FL"},{"description":"Participants with DLBCL received pola, 1.8 mg/kg, as IV infusion on Day 2 of Cycle 1 (each cycle is 21 days), and thereafter on Day 1 of Cycles 2 to 6. Participants also received bendamustine 90 mg/m\\^2, as IV infusion on Days 2 and 3 of Cycle 1, and thereafter on Days 1 and 2 of Cycles 2 to 6 and rituximab, 375 mg/m\\^2, as IV infusion on Day 1 of Cycles 1 to 6, in combination with pola.","id":"OG002","title":"Arm C (Phase II Randomization): Pola+BR in DLBCL"},{"description":"Participants with DLBCL received bendamustine 90 mg/m\\^2, as IV infusion on Days 2 and 3 of Cycle 1 (each cycle is 21 days), thereafter on Days 1 and 2 of Cycles 2 to 6 in combination with rituximab, 375 mg/m\\^2, as IV infusion on Day 1 of Cycles 1 to 6.","id":"OG003","title":"Arm D (Phase II Randomization): BR in DLBCL"},{"description":"Participants with FL received pola, 1.8 mg/kg, as IV infusion on Day 2 of Cycle 1 (each cycle is 28 days), and thereafter on Day 1 of Cycles 2 to 6. Participants also received bendamustine 90 mg/m\\^2, as IV infusion on Days 2 and 3 of Cycle 1, and thereafter on Days 1 and 2 of Cycles 2 to 6 and obinutuzumab 1000 mg, as IV infusion on Days 1, 8, and 15 of Cycle 1 and on Day 1 of Cycles 2 to 6 in combination with pola.","id":"OG004","title":"Arm E (Phase II Expansion): Pola+BG in FL"},{"description":"Participants with DLBCL received pola, 1.8 mg/kg, as IV infusion on Day 2 of Cycle 1 (each cycle is 21 days), and thereafter on Day 1 of Cycles 2 to 6. Participants also received bendamustine 90 mg/m\\^2, as IV infusion on Days 2 and 3 of Cycle 1, and thereafter on Days 1 and 2 of Cycles 2 to 6 and obinutuzumab 1000 mg, as IV infusion on Days 1, 8, and 15 of Cycle 1 and on Day 1 of Cycles 2 to 6 in combination with pola.","id":"OG005","title":"Arm F (Phase II Expansion): Pola+BG in DLBCL"}],"paramType":"MEAN","populationDescription":"ITT population included all randomized participants in Arms A-F (Phase II) irrespective of whether or not they received the study treatment. 'Overall Number Analysed' =number of participants with data available for analysis. 'Number of Participants Analyzed'=number of participants evaluable for this outcome measure. Participants from Arm F did not answer a sufficient number of questions at both baseline and end of treatment visit therefore the average score could not be calculated.","reportingStatus":"POSTED","timeFrame":"Every week during treatment (up to 24 weeks) and for the first 2 months after treatment, thereafter every month for 10 months or until withdrawal (up to 18 months overall)","title":"Symptom Severity and Interference According to Therapy-Induced Neuropathy Assessment Score (TINAS) in Arms A-F","type":"SECONDARY","unitOfMeasure":"Points on scale"}